welcome
Reuters

Reuters

Health

Health

J&J beats quarterly sales and profit estimates on cancer drug sales

Reuters
Summary
Nutrition label

77% Informative

New Jersey -based drugmaker also expects 2025 sales of between $90.9 billion and $91.7 billion .

Fourth-quarter sales stood at $22.52 billion , up 5.3% from a year ago .

Last week , J&J announced a $14.6 billion deal for Intra-Cellular - its biggest deal in two years - to boost its psychiatric drugs portfolio.

VR Score

89

Informative language

97

Neutral language

24

Article tone

formal

Language

English

Language complexity

38

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links